title: [Treatment of febrile convulsions].
abstract: Information and reassurance of parents are essential before considering therapeutic measures following a first febrile seizure. It must be emphasized that, although impressive, febrile convulsions are essentially benign, and that in the majority of cases there will be no recurrence. Apart from that, therapeutic measures are of limited efficacy in order to prevent reocurrence. The correct use of antipyretic treatment during febrile episodes must be specified. Due to its several inconveniences, oral diazepam as an intermittent prophylaxis should be only considered in case of multiple reoccurrences. There is little place for continuous anticonvulsant treatment.
authors.affiliation: Service de pédiatrie, centre hospitalier régional universitaire, 2, boulevard Tonnellé, 37044 Tours, France. autret-leca@med.univ-tours.fr
authors.forename: E
authors.initials: E
authors.lastname: Autret-Leca
authors.forename: J L
authors.initials: JL
authors.lastname: Ployet
authors.forename: A P
authors.initials: AP
authors.lastname: Jonville-Bera
mesh_terms: D000367:Age Factors; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D002220:Carbamazepine / Q000627:therapeutic use; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012307:Risk Factors; D003294:Seizures, Febrile / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D013997:Time Factors; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D003975:Diazepam; D010634:Phenobarbital